From Symptom to Surrogate Endpoint: Where Does Cough Fit in IPF Drug Development
Time: 2:15 pm
day: Day One Track B PM
Details:
• Despite the significance of cough to patients with IPF, there is limited understanding of cough mechanisms, whether inflammatory, fibrotic, sensory
• Investigating cough as a surrogate endpoint in clinical trials for disease progression and treatment efficacy
• Coverage of design and validation of cough specific clinical trial design